English | Español
Jamie Barrand | Dec 10, 2015

Boehringer Ingelheim researchers test nintedanib on patients with severe lung disease
Jamie Barrand | Dec 10, 2015

FDA grants priority review to Pfizer cancer treatment
Jamie Barrand | Dec 8, 2015

Pfizer awards more than $4 million in grants for breast cancer research programs
Jamie Barrand | Dec 8, 2015

FDA approves Pfizer's new chewable ADHD treatment
Jamie Barrand | Dec 8, 2015

Breakthrough could spur diabetes therapy development
Jamie Barrand | Dec 8, 2015

Treatment for rare Wolman disease wins FDA approval
Jamie Barrand | Dec 7, 2015

Slavitt speaks at HHS pharmaceutical forum
Jamie Barrand | Dec 7, 2015

Allergan partners with Rugen Therapeutics to develop autism, OCD therapies

Trending
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 2, 2025

Mutations in blood stem cells may reduce Alzheimer's risk